FIELD: medicine. SUBSTANCE: combination consists of angiotensin II-mediated compound or its salt and, at least, one compound chosen out of a compound with activity in higher sensitivity to insulin, a compound with activity in improved hyperglycemia as a result of food intake in case of diabetes mellitus, indane derivative with activity in inhibiting an angiotensin-converting enzyme, pyridine derivative with activity in inhibiting HMG-CoA reductase, and their salts. Pharmaceutical combination demonstrates efficient action along with relatively decreased dose and decreased number of side effects. EFFECT: higher efficiency. 15 cl
